FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2584681144> ?p ?o ?g. }

• W2584681144 endingPage "844" @default.
• W2584681144 startingPage "837" @default.
• W2584681144 abstract "Objective: Aldosterone excess has been equally associated with resistant hypertension (RHT) and obstructive sleep apnoea (OSA). We conducted a randomized controlled study to assess the effect of continuous positive airway pressure (CPAP) treatment on 24-h urinary aldosterone excretion in patients with RHT and moderate/severe OSA. Methods: A total of 117 patients were randomized (57 CPAP and 60 control groups). Aldosterone excretion was determined by 24 h urine (24h-UAldo) collected at randomization and after 6 months of follow-up. Twenty-four hour UAldo differences were assessed by general linear model with the allocation group (CPAP or control) as a fixed factor adjusted for their respective baseline values. Both intention-to-treat and per-protocol (45 patients with optimal adherence to CPAP) analyses were performed. Results: Baseline 24h-UAldo was higher in severe OSA than in moderate OSA patients. After CPAP treatment, there was a borderline significant reduction in 24h-UAldo [mean difference: −2.5 μg/24 h; 95% confidence interval (95% CI): −5.3 to +0.3 μg/24 h; P = 0.07] in intention-to-treat analysis, whereas in the per-protocol analysis, the CPAP group had a greater reduction in 24h-UAldo than the control group (mean difference: −3.3 μg/24 h; 95% CI: −6.1 to −0.4 μg/24 h; P = 0.027). This effect occurred solely in patients with uncontrolled ambulatory BPs, and was more pronounced in those with the nondipping pattern, not using spironolactone, less obese, and with lowest sleep SaO2 levels. Conclusion: Only optimal CPAP treatment reduced aldosterone excretion in patients with uncontrolled RHT, while on intention-to-treat the effect was borderline. Although nondefinitive, our results suggest that CPAP treatment might improve cardiovascular outcomes by reducing aldosterone excess in resistant hypertensive individuals with OSA. Clinical Trial Registration: ClinicalTrials.gov Identifier: NCT01508754." @default.
• W2584681144 created "2017-02-10" @default.
• W2584681144 creator A5014358433 @default.
• W2584681144 creator A5016104115 @default.
• W2584681144 creator A5034004735 @default.
• W2584681144 creator A5035403410 @default.
• W2584681144 creator A5057508104 @default.
• W2584681144 creator A5059024669 @default.
• W2584681144 date "2017-04-01" @default.
• W2584681144 modified "2023-10-18" @default.
• W2584681144 title "Effects of continuous positive airway pressure treatment on aldosterone excretion in patients with obstructive sleep apnoea and resistant hypertension" @default.
• W2584681144 cites W1565126995 @default.
• W2584681144 cites W1797367453 @default.
• W2584681144 cites W1847386200 @default.
• W2584681144 cites W1972155258 @default.
• W2584681144 cites W1973686627 @default.
• W2584681144 cites W1979742611 @default.
• W2584681144 cites W1988676844 @default.
• W2584681144 cites W1995501138 @default.
• W2584681144 cites W2002557448 @default.
• W2584681144 cites W2011763007 @default.
• W2584681144 cites W2018230139 @default.
• W2584681144 cites W2060318133 @default.
• W2584681144 cites W2071529950 @default.
• W2584681144 cites W2076462334 @default.
• W2584681144 cites W2077607137 @default.
• W2584681144 cites W2078034814 @default.
• W2584681144 cites W2079485496 @default.
• W2584681144 cites W2086111363 @default.
• W2584681144 cites W2098077186 @default.
• W2584681144 cites W2098352519 @default.
• W2584681144 cites W2114339665 @default.
• W2584681144 cites W2117041380 @default.
• W2584681144 cites W2118344567 @default.
• W2584681144 cites W2118826211 @default.
• W2584681144 cites W2118958399 @default.
• W2584681144 cites W2119080429 @default.
• W2584681144 cites W2122915712 @default.
• W2584681144 cites W2132646664 @default.
• W2584681144 cites W2133667581 @default.
• W2584681144 cites W2135100154 @default.
• W2584681144 cites W2137197948 @default.
• W2584681144 cites W2137574560 @default.
• W2584681144 cites W2156903075 @default.
• W2584681144 cites W2161355380 @default.
• W2584681144 cites W2166761488 @default.
• W2584681144 cites W2166963401 @default.
• W2584681144 cites W2257687534 @default.
• W2584681144 cites W4294830572 @default.
• W2584681144 cites W4294915483 @default.
• W2584681144 doi "https://doi.org/10.1097/hjh.0000000000001254" @default.
• W2584681144 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28129246" @default.
• W2584681144 hasPublicationYear "2017" @default.
• W2584681144 type Work @default.
• W2584681144 sameAs 2584681144 @default.
• W2584681144 citedByCount "22" @default.
• W2584681144 countsByYear W25846811442017 @default.
• W2584681144 countsByYear W25846811442018 @default.
• W2584681144 countsByYear W25846811442019 @default.
• W2584681144 countsByYear W25846811442020 @default.
• W2584681144 countsByYear W25846811442021 @default.
• W2584681144 countsByYear W25846811442022 @default.
• W2584681144 crossrefType "journal-article" @default.
• W2584681144 hasAuthorship W2584681144A5014358433 @default.
• W2584681144 hasAuthorship W2584681144A5016104115 @default.
• W2584681144 hasAuthorship W2584681144A5034004735 @default.
• W2584681144 hasAuthorship W2584681144A5035403410 @default.
• W2584681144 hasAuthorship W2584681144A5057508104 @default.
• W2584681144 hasAuthorship W2584681144A5059024669 @default.
• W2584681144 hasConcept C10146269 @default.
• W2584681144 hasConcept C126322002 @default.
• W2584681144 hasConcept C149323552 @default.
• W2584681144 hasConcept C168563851 @default.
• W2584681144 hasConcept C204243189 @default.
• W2584681144 hasConcept C2776006263 @default.
• W2584681144 hasConcept C2776379505 @default.
• W2584681144 hasConcept C2778525890 @default.
• W2584681144 hasConcept C2779547634 @default.
• W2584681144 hasConcept C35785553 @default.
• W2584681144 hasConcept C42219234 @default.
• W2584681144 hasConcept C44249647 @default.
• W2584681144 hasConcept C71924100 @default.
• W2584681144 hasConceptScore W2584681144C10146269 @default.
• W2584681144 hasConceptScore W2584681144C126322002 @default.
• W2584681144 hasConceptScore W2584681144C149323552 @default.
• W2584681144 hasConceptScore W2584681144C168563851 @default.
• W2584681144 hasConceptScore W2584681144C204243189 @default.
• W2584681144 hasConceptScore W2584681144C2776006263 @default.
• W2584681144 hasConceptScore W2584681144C2776379505 @default.
• W2584681144 hasConceptScore W2584681144C2778525890 @default.
• W2584681144 hasConceptScore W2584681144C2779547634 @default.
• W2584681144 hasConceptScore W2584681144C35785553 @default.
• W2584681144 hasConceptScore W2584681144C42219234 @default.
• W2584681144 hasConceptScore W2584681144C44249647 @default.
• W2584681144 hasConceptScore W2584681144C71924100 @default.
• W2584681144 hasIssue "4" @default.
• W2584681144 hasLocation W25846811441 @default.
• W2584681144 hasLocation W25846811442 @default.

• next